Exoskeleton-Assisted Walking for Pulmonary and Exercise Performances of SCI Individuals.
Study Goal
To determine if exoskeleton-assisted walking (EAW) improves pulmonary ventilation, motor function, and daily activities as effectively as conventional exercise in people with spinal cord injury (SCI).
Results Summary
EAW improved forced vital capacity, predicted FVC%, forced expiratory volume, basic activities of daily living, and distal femoral cartilage more than conventional exercise. No differences were found in trunk/lower extremity motor function, bone mineral density, or adverse events.
Population
40 participants (7 females, 33 males; age 37.1±12.0 years) with thoracic SCI.
Effective Dosage
16 sessions of 50-60 min training (4 days/week).
Duration
4 weeks (16 sessions).
Interactions
None mentioned.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
exoskeleton-assisted walking (EAW) training | increase | forced vital capacity (FVC) | people with spinal cord injury (SCI) | 0.53 L [0.01-1.06 L] | improved more than the control group | #1 |
exoskeleton-assisted walking (EAW) training | increase | predicted FVC% | people with spinal cord injury (SCI) | 19.59 [6.63-32.54] | improved more than the control group | #2 |
exoskeleton-assisted walking (EAW) training | increase | forced expiratory volume in 1s | people with spinal cord injury (SCI) | 0.61 L [0.15-1.07 L] | improved more than the control group | #3 |
exoskeleton-assisted walking (EAW) training | increase | basic activities of daily living (BADL) | people with spinal cord injury (SCI) | 19.75 [10.88-28.62] | improved more than the control group | #4 |
exoskeleton-assisted walking (EAW) training | increase | distal femoral cartilage | people with spinal cord injury (SCI) | - | improved more than the control group | #5 |
exoskeleton-assisted walking (EAW) training | neutral | 6-minute walk test | people with spinal cord injury (SCI) | median 17.3 meters | completed | #6 |
exoskeleton-assisted walking (EAW) training | no change | trunk and lower extremity motor function | people with spinal cord injury (SCI) | - | no difference | #7 |
exoskeleton-assisted walking (EAW) training | no change | bone mineral density | people with spinal cord injury (SCI) | - | no difference | #8 |
exoskeleton-assisted walking (EAW) training | no change | adverse events | people with spinal cord injury (SCI) | - | no difference | #9 |
exoskeleton-assisted walking (EAW) training | increase | pulmonary ventilation function | people with lower thoracic neurological level of SCI | - | has potential benefits to facilitate | #10 |
exoskeleton-assisted walking (EAW) training | increase | walking | people with lower thoracic neurological level of SCI | - | has potential benefits to facilitate | #11 |
exoskeleton-assisted walking (EAW) training | increase | BADL | people with lower thoracic neurological level of SCI | - | has potential benefits to facilitate | #12 |
exoskeleton-assisted walking (EAW) training | increase | thickness of cartilage | people with lower thoracic neurological level of SCI | - | has potential benefits to facilitate | #13 |
OBJECTIVE: To determine whether exoskeleton-assisted walking (EAW) improves pulmonary ventilation function, motor function and related body structure, and activities equivalently as the conventional exercise program for people with spinal cord injury (SCI). METHODS: Forty participants (7 females and 33 males; age 37.1±12.0 years) with thoracic SCI were randomized into two groups and undertook 16 sessions of 50-60 min training (4 days/week). Participants in the EAW group received EAW trainings, such as assisted standing, walking, and climbing the stairs. The control group received a conventional exercise program. Outcomes were measured at baseline and upon completion of treatment. RESULTS: After trainings, the EAW group improved more than the control group in the forced vital capacity (FVC, 0.53 L [0.01-1.06 L]), predicted FVC% (19.59 [6.63-32.54]) and forced expiratory volume in 1s (0.61 L [0.15-1.07 L]), basic activities of daily living (BADL) (19.75 [10.88-28.62]), and distal femoral cartilage. Participants in the EAW group completed 6-minute walk test with median 17.3 meters while wearing the exoskeleton. There was no difference in trunk and lower extremity motor function, bone mineral density, and adverse events ( P > 0.05). CONCLUSION: In people with lower thoracic neurological level of SCI, EAW training has potential benefits to facilitate pulmonary ventilation function, walking, BADL and thickness of cartilage comparing to a conventional excise program. SIGNIFICANCE: This study provided more evidence for using EAW in clinic, and partly proved EAW had equivalent effects as conventional exercise program, which may combine with conventional exercise program for reducing burden of therapists in the future.